|
Volumn 36, Issue 7, 2018, Pages 555-
|
Wanted: A reward for antibiotic development
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
MONOBACTAM DERIVATIVE;
NEW DRUG;
ANTIINFECTIVE AGENT;
ACINETOBACTER BAUMANNII;
ANTIBIOTIC RESISTANCE;
DRUG APPROVAL;
DRUG MARKETING;
DRUG PROGRAM;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HUMAN;
INTERNATIONAL COOPERATION;
INVESTMENT;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MYCOBACTERIUM TUBERCULOSIS;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
PSEUDOMONAS AERUGINOSA;
REIMBURSEMENT;
DRUG EFFECT;
GENETICS;
PATHOGENICITY;
ANTI-BACTERIAL AGENTS;
DRUG RESISTANCE, BACTERIAL;
GOVERNMENT;
HUMANS;
MYCOBACTERIUM TUBERCULOSIS;
|
EID: 85049690370
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.4193 Document Type: Editorial |
Times cited : (28)
|
References (0)
|